General MedicationsINJECTIONGeneric

METHOTREXATE SODIUM PRESERVATIVE FREE

METHOTREXATE SODIUM

Standard Dose

EQ 200MG BASE/8ML (EQ 25MG BASE/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview METHOTREXATE SODIUM PRESERVATIVE FREE is listed in Drugs@FDA under application 201529 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/8ML (EQ 25MG BASE/ML) Sponsor EUGIA PHARMA SPECLTS Submission history Latest submission status date: 2021-07-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHOTREXATE SODIUM PRESERVATIVE FREE is listed in Drugs@FDA under application 201529 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/8ML (EQ 25MG BASE/ML) Sponsor EUGIA PHARMA SPECLTS Submission history Latest submission status date: 2021-07-19 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.